These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30516293)

  • 1. Does DRG funding encourage hospital specialization? Evidence from the Italian National Health Service.
    Anessi-Pessina E; Nieddu L; Rizzo MG
    Int J Health Plann Manage; 2019 Apr; 34(2):534-552. PubMed ID: 30516293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital services and casemix in Western Australia.
    Hendrie D; Boldy D
    Aust Health Rev; 2002; 25(1):173-88. PubMed ID: 11974956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of reimbursement mechanisms on medical technology diffusion in the hospital sector in the Italian NHS.
    Finocchiaro Castro M; Guccio C; Pignataro G; Rizzo I
    Health Policy; 2014 Apr; 115(2-3):215-29. PubMed ID: 24393709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do diagnosis-related group-based payments incentivise hospitals to adjust output mix?
    Liang LL
    Health Econ; 2015 Apr; 24(4):454-69. PubMed ID: 24519749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public versus private hospital maternity length of stay: a gamma mixture modelling approach.
    Lee AH; Xiao J; Codde JP; Ng AS
    Health Serv Manage Res; 2002 Feb; 15(1):46-54. PubMed ID: 11854995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The funding of private hospitals in Australia.
    Bloom AL
    Aust Health Rev; 2002; 25(1):19-39. PubMed ID: 11974958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has DRG payment influenced the technical efficiency and productivity of diagnostic technologies in Portuguese public hospitals? An empirical analysis using parametric and non-parametric methods.
    Dismuke CE; Sena V
    Health Care Manag Sci; 1999 May; 2(2):107-16. PubMed ID: 10916607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have DRG-based prospective payment systems influenced the number of secondary diagnoses in health care administrative data?
    Serdén L; Lindqvist R; Rosén M
    Health Policy; 2003 Aug; 65(2):101-7. PubMed ID: 12849909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Funding of South Australian public hospitals.
    Moss J
    Aust Health Rev; 2002; 25(1):156-72. PubMed ID: 11974955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of introducing a new hospital financing system (DRGs) in Poland on hospitalisations for atherosclerosis: An interrupted time series analysis (2004-2012).
    Buczak-Stec E; Goryński P; Nitsch-Osuch A; Kanecki K; Tyszko P
    Health Policy; 2017 Nov; 121(11):1186-1193. PubMed ID: 28967491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A DRG based future hospital funding scheme: state of implementation and impact in the field of rehabilitation].
    Rochell B; Roeder N
    Rehabilitation (Stuttg); 2002 Feb; 41(1):1-9. PubMed ID: 11830787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition policy for health care provision in Norway.
    Brekke KR; Straume OR
    Health Policy; 2017 Feb; 121(2):134-140. PubMed ID: 27916434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital specialization and cost efficiency: benefits of trimming product lines.
    Eastaugh SR
    Hosp Health Serv Adm; 1992; 37(2):223-35. PubMed ID: 10118589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casemix perspectives for clinicians in the private sector.
    Maxwell CN
    Med J Aust; 1998 Oct; 169(S1):S48-50. PubMed ID: 9830414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new clinical complexity model for the Australian Refined Diagnosis Related Groups.
    Dimitropoulos V; Yeend T; Zhou Q; McAlister S; Navakatikyan M; Hoyle P; Pilla J; Loggie C; Elsworthy A; Marshall R; Madden R
    Health Policy; 2019 Nov; 123(11):1049-1052. PubMed ID: 31506190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New forms of remuneration and care delivery: their impact on rehabilitation].
    Haaf HG; Volke E; Schliehe F
    Rehabilitation (Stuttg); 2004 Oct; 43(5):312-24. PubMed ID: 15472790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of casemix on the care of the elderly.
    Finnegan TP
    Z Gerontol Geriatr; 2001 Jun; 34(3):170-5. PubMed ID: 11487958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?
    Bonastre J; Chevalier J; Van der Laan C; Delibes M; De Pouvourville G
    Health Policy; 2014 Jun; 116(2-3):162-9. PubMed ID: 24314625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new financing system in the Italian National Health Service. Implications for internal medicine].
    Anessi Pessina E
    Minerva Med; 1998; 89(1-2):29-45. PubMed ID: 9561023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of DRG Payment in France: issues and recent developments.
    Or Z
    Health Policy; 2014 Aug; 117(2):146-50. PubMed ID: 24962536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.